It’s no secret: Big Pharma is in big trouble. The industry faces losing $66 billion in sales to generics over the next five years as patented drugs lose protected status. Pharmaceutical firms are fighting back by pumping record dollars into R&D, yet companies only won FDA approval last year for 21 new drugs. To increase their odds of success, global Pharma giants are looking for ever-better ways to revitalize their pipelines by developing novel and innovative programs, partnerships, and approaches to fostering innovation. As the world’s leading center of life sciences innovation, Boston is the hub of much of this activity. This forum will bring together pharmaceutical industry leaders, biotech executives, and startup entrepreneurs to highlight what’s happening on the front lines of innovation.
Keynote speakers: Deborah Dunsire, CEO, Millennium: The Takeda Oncology Company Christoph Westphal, CEO, Sirtris, SVP, Centre of Excellence for External Drug Discovery, GlaxoSmithKline
Featured speakers and panelists include: Jean George, General Partner, Advanced Technology Ventures Tuan Ha-Ngoc, President and CEO, Aveo Pharmaceuticals Russell Herndon, President and CEO, Hydra Biosciences Campbell Murray, Managing Director, Novartis Venture Funds David Steinberg, Founding CEO, Enlight Biosciences Joseph Yanchik III, President and CEO, Aileron Therapeutics Daphne Zohar, Founder and Managing Partner, PureTech Ventures
This recognized student group does not
discriminate on the basis of race, color, religion, disability, sexual orientation, national origin, sex or age. The
views and opinions expressed on this page are solely those of the page author.
